1
Registered trials
0
Recruiting
1
Unique sponsors
2
Unique IMPs
1
Commercial trials
Drug classes (ATC)
L
Oncology (ATC L)
1
Mechanism of action (INN-stem analysis)
Monoclonal antibody
1 substance
Unknown / small molecule
1 substance
Phase I/II:
1
Phase I/II
1 trial-
EndedTransgene CommercialAVELUMAB; TIPAPKINOGENE SOVACIVEC
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Transgene | Commercial | 1 | Phase I/II | 0 |